4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-027305
Chairman and CEO bought 8,000 shares at an average $1.24 ($9,890)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-05-01 | Purchase | +5,000 | $1.21 | $6,050 | 10,607,243 | D |
| Niihara Yutaka Chairman and CEO | 2020-05-04 | Purchase | +3,000 | $1.28 | $3,840 | 10,610,243 | D |
| Open-market purchases · 8,000 sh · avg $1.24 · $9,890 | |||||||
Loading xslF345X03/doc4.xml…